TrialPanorama/Dataset huggingface dataset:
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Reaching High Risk Post-partum Women for Nutritional Assessment and Counseling Via a Telephone-based Coaching Program
Brief Summary: The purpose of the STAR-MAMA intervention is to develop a patient-tailored telephone-base counseling intervention for young Latino women who are at high risk of diabetes. The intervention will focus at the end of pregnancy and the 9 months post-partum period to improve education and behavioral counseling on nutrition and other related health topics .

The following hypotheses will be formally tested:

Compared with controls at 9 months post-partum:

1. Women in the STAR-Moms program will have improved self-reported behavioral outcomes for minutes of physical activity, lower fat diet, and breast-feeding duration (in weeks);
2. Women in the STAR-Moms program will have improved diabetes prevention knowledge;
3. Women in the STAR-Moms program will have increased diabetes-relevant screening rates.

Women in the STAR-MAMA will have lost more weight than women in the control group.


Options:
A: Inclusion Criteria:

* Self-identified as a first generation Korean American
* Age 30 years or older
* Resides in Washington-Baltimore area
* Expresses willingness to participate in all aspects of the study over its full course
* Written consent to participate in the screening/eligibility visit
* Self-identified with DM and HbA1c \>= 8% within 6 months of screening
* Written consent to participate in the clinical trial: agreeing to participate in study data collection procedures, receiving DM self -help education, using HGMT, and permitting contact with their own medical care provider.

Exclusion Criteria:

* Unable to give informed consent
* Physical or mental health conditions that could limit active participation in the study (e.g., blindness in both eyes, severe immobility, psychiatric diseases)
* Hematological condition that would affect A1C assay, e.g., hemolytic anemia, sickle cell anemia.
B: Inclusion Criteria:

* Most recent phosphorus and mean phosphorus over last 3 months \> 5.5 mg/dL
* Age ≥ 18 years
* On chronic hemodialysis ≥ 6 months
* English speaking

Exclusion Criteria:

* Mentally incompetent
* AIDS
* Cancer
* Terminal illness
* Pregnancy
* Nursing home residence
* No telephone access
* In another phosphorus related study
* Unable to identify written words
C: Inclusion Criteria:

* Latina
* 35 to 64 years of age
* body mass index (BMI) \>25
* fluent in either Spanish or English.

Exclusion Criteria:

* pregnant or planning to get pregnant in next year
* history of myocardial infarction or stroke
* currently under treatment for cancer
* orthopedic or joint problems that would prohibit participation in physical activity
* insulin-dependent diabetes
D: Inclusion Criteria:

* Postpartum Latino women (English or Spanish speakers) with history of gestational diabetes.
* 18 years or older

Exclusion Criteria:

* Do not have type 1 or type 2 diabetes.
* Do not have access to phone line or a cellphone to receive weekly calls of health coaching education over the phone.

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Electroencephalography Guidance of Anesthesia to Alleviate Geriatric Syndromes (ENGAGES) Study
Brief Summary: This study aims to determine whether, compared with usual anesthetic care, an electroencephalography-guided anesthesia protocol is effective at preventing postoperative delirium and its downstream effects, and improving postoperative patient reported health-related quality of life.


Options:
A: Inclusion Criteria:

* Adult patients (\>65 years old)
* Scheduled for elective surgery requiring general anesthesia at LLUMC HSH
* Airway management expected to include endotracheal intubation
* Expected surgical duration 120 to 240 minutes

Exclusion Criteria:

* Pre-existing significant psychiatric disease or mental status changes
* Clinically significant cardiovascular, respiratory, hepatic, renal,neurological, psychiatric, or metabolic disease
* Patient's weighing \>50% ideal body weight

  * Men: Ideal Body Weight (in kilograms) = 50 + 2.3 kg per inch over 5 feet
  * Women: Ideal Body Weight (in kilograms) = 45.5 + 2.3kg per inch over 5 feet
* Patients who have undergone a general anesthetic within the past 7 days
* Patient refusal
B: Inclusion Criteria:

MUST HAVE:

General Anesthesia with volatile anesthetic

PATIENT CHARACTERISTICS

Major Criteria (Must have any 1 of the following:)

1. Planned open heart surgery
2. Medications - anticonvulsants, abuse of opiates, benzodiazepines, cocaine
3. EF\<40%
4. Prior history of awareness (recall)
5. History of difficult intubation or anticipated difficult intubation
6. ASA IV or V status
7. Aortic stenosis
8. End stage lung disease
9. Marginal exercise tolerance not secondary to musculoskeletal dysfunction
10. Pulmonary hypertension
11. Daily alcohol consumption

Exclusion Criteria:

1. Surgical procedure that prevents the use of the BIS (e.g. surgery of forehead)
2. Patient positioning prevents use of the BIS
3. Surgery with wake-up test.
4. Less than 18 years of age
5. Vulnerable populations, such as those with dementia and those unable to provide informed consent.
6. Stroke with residual neurological deficits

   -
C: Inclusion Criteria:

* patients scheduled for cardiac surgery

Exclusion Criteria:

* pregnancy
D: Inclusion:

* Patients 60 years old and older,
* Competent to provide informed consent
* Undergoing major elective surgery that requires a minimum stay of 2 days postoperatively (e.g., open cardiac surgery, open thoracic surgery, major vascular surgery, intra-abdominal surgery, open gynecologic surgery, open urologic surgery, major orthopedic surgery, open hepato-biliary surgery and major ear, nose and throat surgery)

Exclusions

* Neurosurgical procedures will be excluded as surgery on the brain can confound the outcome (postoperative delirium).
* Patients with preoperative delirium and patients who are unable to participate adequately in delirium screening including those who are blind, deaf, or illiterate or fluent in languages other than English.

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Tools to Improve Parental Recognition of Developmental Deficits in Children
Brief Summary: In this study, we aim to improve child nutrition by increasing parents' awareness of their children's physical growth. We use a cluster-randomized trial design to evaluate two interventions that provide parents with regular information on their children's physical development and growth: 1) distribution of full-sized growth charts for measurement of child height within households; and 2) organization of community-based meetings, during which children's height and weight are measured by trained project staff.


Options:
A: For Phase 1:

Inclusion Criteria:

* Malaysian
* Children aged 3 to 5 years old
* Mothers aged above 18 years old
* Living in public low-cost PPR flat

Exclusion Criteria:

* Children who are taken care by other adults rather than mothers such as father, grandparents and caregivers
* Mothers with mental disabilities
* Children with history of chronic diseases including congenital heart disease, liver disease, renal failure or sickle cell disease and any congenital abnormalities
* Children who are under treatment for communicable disease such as measles and chickenpox
* Children with learning disabilities
* Mother-child dyads involved in any other intervention or clinical research
* Children who are overweight or obese

The respondents' selection criteria in Phase 2 are almost similar as in Phase 1 except for the second inclusion criterion that is related to children. In Phase 2, only undernourished children (either underweight, stunting or wasting) aged 3 to 5 years old will be recruited in order to evaluate the effectiveness of the intervention in this particular group. The exclusion criteria in Phase 2 are similar to the exclusion criteria in Phase 1.
B: Inclusion Criteria:

* child in household in designated study area of Nepal, age 1 month to 12 years
* family agrees to enrollment

Exclusion Criteria:

* parent refuse to enroll child
C: Inclusion Criteria:

* All households with a child between the ages of 6 and 18 months at baseline

Exclusion Criteria:

* None
D: Inclusion Criteria:

* A lead caretaker with a 6-8 months infant (child/lead caretaker pair) who will have given consent to participate in the study. If there is more than one child of the age in the household, the younger one will be taken as the index/study child.

Exclusion Criteria:

* Is older than 8 months at baseline
* Congenital malformations or physical handicap that may influence growth or interfere with taking of anthropometric measurements
* Disability that will influence nutrient intake
* Been diagnosed with mental or brain illness as evidenced by mother or health worker.
* If the family that is likely to emigrate during the study period

Answer: C
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Tools for Teen Moms: Reducing Infant Obesity Risk
Brief Summary: The purpose of this social media group randomized trial (GRT) is to test the feasibility of our Baby Dayr for Teen Moms intervention to increase maternal responsiveness to infant cues and implement healthy feeding practices through development of a healthy feeding style.

Aim 1: Evaluate the feasibility and acceptability of the Baby Dayr intervention administered to the target population as it relates to their acceptance and satisfaction with the content, format, delivery, and use of social media.

Aim 2: Explore efficacy of the Baby Dayr intervention administered to adolescent mothers of infants 4 months of age or less as assessed by maternal responsiveness, feeding style, and feeding practices evaluated at the completion of the intervention using self-report methods.


Options:
A: Inclusion Criteria:

* Self-identified, English-speaking
* Low-income, adolescent
* First-time mothers between the ages of 14 and 19
* With daily web access and access to a cell phone that includes text messaging capabilities
* Family income ≤ 185% of federal poverty
* Term birth (37≤42 weeks, 2500≤3750 grams birth weight)
* Mothers and infants with no special nutrients or feeding needs
* Infants less than six weeks old at study enrollment who have not started eating solid foods
* Adolescent mothers must be a primary caretaker of the infant who feeds her infant at least once a day, and who is willing to participate in a six-week intervention with data collection at three defined time points (T1, T2, and T3)

Exclusion Criteria:

* Male caregivers
* Mothers and infants with diagnosed feeding/eating disorders
* Significant perinatal or postnatal complications
* Post partum depression or other mental health problems
* Adolescent mothers who do not share in the feeding responsibility of their infants
* Adolescents without daily web access nor a cell phone with text messaging capabilities
B: Inclusion Criteria:

* Infants aged 6-7 months at the time of recruitment into the study
* Infants currently being breastfed
* Parents (or caregivers) anticipated local residence for the study duration

Exclusion Criteria:

* Congenital or chronic abnormalities impairing feeding or physical growth measurements
* Oedema
* Severely ill or clinical complications warranting hospitalisation
C: Inclusion Criteria:

* 1. Have a child 2 and under in their care 2. Consider themselves Latina 3. Are Spanish-speaking

Exclusion Criteria:

Exclude if child has major medical issues interfering with feeding
D: Inclusion Criteria:

* Mother of child between the ages of 3 and 12 months and her child

Exclusion Criteria:

* N/A

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Hemiarthroplasty Compared to Total Hip Arthroplasty for Displaced Femoral Neck Fractures in the Elderly-elderly. A Randomized Controlled Trial.
Brief Summary: Total Hip Arthroplasty is equal to or better than Hemiarthroplasty in the treatment of displaced femoral neck fractures in the elderly-elderly


Options:
A: Inclusion Criteria:

* patients diagozied with acute intertrochantric unstable fracture
* a minimum minimental score of 6
* ability to walk 500 meters indepedently

Exclusion Criteria:

* pathological fracture
* multiple fractures
* neurological conditions
B: Inclusion Criteria:

* Undisplaced (Garden I-II) femoral neck fracture (within 72h)
* treated at participating unit
* informed consent
* amenable for both treatment options

Exclusion Criteria:

* no informed consent
* pathological or stress fracture
* peri-implant fracture
C: Inclusion Criteria:

* Acute Displaced femoral neck fracture
* Subject is aged between 65-79 years
* Independent walker with or without walking aides
* Subject is able and capable of providing consent to participate in the study

Exclusion Criteria:

* Patients with Rheumatoid Arthritis
* Patients with an impaired cognitive dysfunction
* Patients with Pathological fractures
* Patients with substance abuse
* Patients with fracture older than 36-hours on arrival at the A\&E
* Patients suffering from cancer
* Patients determined by principal investigator to be unsuitable for inclusion
D: Inclusion Criteria:

* Acute displaced femoral neck fracture of hip (Garden classification 3-4)
* Independent walker with or without walking aides
* Patient willing to participate in the study and give written consent.

Exclusion Criteria:

* Fracture older than 36 hours before admission
* Osteoarthritis in the fractured hip
* Rheumatoid arthritis in the fractured hip
* Pathological fractures
* Contraindication for hip arthroplasty surgery
* Not suitable for inclusion for other reasons e.g. substance abuse

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact
Brief Summary: The eCMP Pilot aims to study the feasibility and potential effectiveness of an electronically-mediated CardioMetabolic Program (eCMP) for therapeutic lifestyle change among adults with or at high risk for type 2 diabetes, heart disease, and/or stroke.


Options:
A: Inclusion Criteria:

* Participants must be interested in the Noom app
* BMI \> 27 kg/m2
* Ages of 18 and 60 at entry to the study
* Speak English

Exclusion Criteria:

* Contraindication to smartphone use (e.g., seizures from prior smartphone use, do not own a smartphone)
* Acute suicide risk
* Pregnant or planning to become pregnant during the study
* Current Noom use
B: Inclusion Criteria:

* Body Mass Index (kg/m2) of 25-45.
* English language fluency
* Ability to read at a 6th grade level
* Availability to attend weekly treatment sessions in Providence, RI

Exclusion Criteria:

* Any heart condition that limits ability to participate in physical activity
* Chest Pain
* Any cognitive of physical limitation that would preclude use of a smartphone
* Serious mental illness
* Historical or current eating disorder
* Previous or planned bariatric surgery
* Use of weight loss medication
* Recent pregnancy or a plan to become pregnant in the next 6 months
* Participation in a study at the Weight Control and Diabetes Research Center within the last two years
* A weight loss of greater than 5% body weight in the last 6 months
C: Inclusion Criteria:

* Obese subjects (IMC ≥ 27.5 to \<40), classified as sedentary according to the short physical activity questionnaire validated in the EVIDENT II study.

Exclusion Criteria:

* Older than 65 years are excluded, due to difficulties in the use of ICTs.
* Advanced respiratory, renal or liver disease.
* Several mental illness
* Coronary or cerebrovascular atherosclerotic disease, grade II or higher NYHA heart failure.
* Moderate or severe COPD
* Muscular-skeletal pathology that inhibit mobility
* Subjects who can not exercise or follow a hypocaloric diet.
* Oncologic disease in treatment diagnosed in the last 5 years.
* Terminal situation
* Pregnancy
* Bariatric surgery
* Those with any other circumstance that the investigators consider could interfere with the study procedures
D: Inclusion Criteria:

* English-speaking adults aged 18+ years
* High-risk primary prevention: BMI 35+ and prediabetes (including hx of gestational diabetes) and/or metabolic syndrome
* Secondary prevention: BMI 30+ and type 2 diabetes and/or cardiovascular disease
* Able and willing to provide written informed consent

Exclusion Criteria:

* Medical determination that the study is inappropriate or unsafe for the patient
* Type 1 diabetes
* Safety concerns related to significant physical or mental health issues or life expectancy of less than 12 months
* Currently pregnant or lactating
* No regular telephone or broadband Internet access or otherwise unable to participate in the intervention

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Study of Prosthesis Choice in Older Patients With a Dislocated Femoral Neck Fracture of the Hip
Brief Summary: The purpose of this study is to evaluate whether an uncemented hip prosthesis is as safe as an cemented hip prosthesis for patients undergoing total hip arthroplasty surgery following a displaced femoral neck fracture.


Options:
A: Inclusion Criteria:

* Fracture of femoral neck
* Operative treatment within 4 days for displaced fractures
* Operative treatment within 7 days for nondisplaced fractures
* Ambulatory before the injury
* Low energy trauma, such as falls from a sitting or standing position
* No other major trauma

Exclusion Criteria:

* Unsuited for both surgical treatments
* Associated major injuries of the lower extremities
* Retained hardware around the hip
* Infection around the hip
* Bone metabolic disorder (except for osteoporosis)
* Moderate or severe cognitive impairment
* Parkinson's disease or dementia
* Unable to complete the 2-year follow-up
B: Inclusion Criteria:

* Written informed consent
* Diagnosis: displaced femoral neck fracture type AO 31-B2 or B3/Garden type 3 or 4
* Eligible for THA according to local guidelines and routines

Exclusion Criteria:

* Previous inclusion of contralateral hip
* Delayed fracture surgery (date of injury \>7 days prior to date of randomization)
* Pathological or stress fracture of the femoral neck, or fracture adjacent to a previous ipsilateral hip implant
* Inability or unwillingness to give written consent
* Dementia (as diagnosed by the screening physician)
* Unavailability of both interventions for a study subject (e.g., implants being out of stock, or lack of the individual surgeon's expertise to perform either procedure)
C: Inclusion Criteria:

Patients \>75 years old who were diagnosed with impacted femoral neck fracture with confirmation of mutual embedding and close combination of the fracture ends by CT or MRI scanning(including Garden 1 and 2 and varus impacted FNF) were eligible for the inclusion.

Exclusion Criteria:

Patients \<75 years old, pathological fracture, nonimpacted or displaced fracture, unable to walk previously, avascular necrosis of femoral head, previous symptomatic hip pathology (such as arthritis), infection, a history of fracture in the studied hip, deformity of lower limb.
D: Inclusion Criteria:

* Acute Displaced femoral neck fracture
* Subject is aged between 65-79 years
* Independent walker with or without walking aides
* Subject is able and capable of providing consent to participate in the study

Exclusion Criteria:

* Patients with Rheumatoid Arthritis
* Patients with an impaired cognitive dysfunction
* Patients with Pathological fractures
* Patients with substance abuse
* Patients with fracture older than 36-hours on arrival at the A\&E
* Patients suffering from cancer
* Patients determined by principal investigator to be unsuitable for inclusion

Answer: D
Please select the eligibility criteria that correspond to the clinical trial below.
Title: N/A
Brief Summary: This study aimed to compare dobutamine stress echocardiography (DES) with computed tomography coronary angiography (CTCA) in patients with undergoing intermediate to high risk noncardiac surgery.


Options:
A: Inclusion Criteria:

* \> 18 years old, with coronary stents
* American Society of Anaesthesia physical status II-V
* noncardiac surgery wiht admission
* informed consent

Exclusion Criteria:

* \< 18 years old
* American Society of Anaesthesia physical status I
* ambulatory surgery
* pregnancy
* obstetric anaesthesia
* endoscopic procedures
* cardiac surgery
* not informed consent
B: DISEASE CHARACTERISTICS:

* Confirmed diagnosis of B-cell chronic lymphocytic leukemia

  * Rai stage 0-II (Binet stage A) disease
* Meets 1 of the following criteria:

  * High-risk disease, as defined by the following:

    * Serum thymidine kinase level \> 7.0 U/L
    * Elevated β2-microglobulin level
    * Presence of non-nodular bone marrow infiltration
    * Short lymphocyte doubling time
  * Low-risk disease

    * Meets none of the criteria (as listed above) for high-risk disease

PATIENT CHARACTERISTICS:

Performance status

* Not specified

Life expectancy

* More than 6 months

Hematopoietic

* No autoimmune hemolytic anemia
* No thrombocytopenia

Hepatic

* Not specified

Renal

* Not specified

Other

* No severe organ dysfunction
* No other prior or concurrent malignancy

PRIOR CONCURRENT THERAPY:

Chemotherapy

* No prior chemotherapy
* No other concurrent chemotherapy
C: Inclusion Criterion:

* Hip fracture diagnosed in Turku Univeristy Hospital between October 2009 and May 2010

Exclusion Criterion:

* Patient refusal
D: Inclusion Criteria:

1. Elective surgery
2. Intermediate or high-risk noncardiac surgeries 1) intermediate risk surgery: intrathoracic, intraperitoneal, orthopedic,head and neck, and prostate 2) high risk surgery: vascular
3. Revised cardiac risk index score ≥1 (more than one of the following criteria) 1) vascular surgery, intraperitoneal, intrathoracic surgery 2) history of ischemic heart disease 3) history of heart failure 4) history of cerebrovascular disease 5) diabetes with insulin treatment 6) chronic kidney disease (serum creatinine \> 2.0 mg/dL)

Exclusion Criteria:

1. Need for emergency surgery
2. Active cardiac conditions 1) recent (within 1 month) myocardial infarction 2) acute decompensated heart failure 3) severe valvular disease 4) fatal cardiac arrhythmia 5) acute pulmonary embolism 6) acute myocarditis
3. Relative contraindications or immeasurable coronary stenosis of the CTCA

Answer: D